Dai L - Search Results

1

Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis.

Fan M, Lin Y, Pan J, Yan W, Dai L, Shen L, Chen K. Fan M, et al. Among authors: dai l. Thorac Cancer. 2016 Mar;7(2):173-81. doi: 10.1111/1759-7714.12299. Epub 2015 Aug 11. Thorac Cancer. 2016. PMID: 27042219 Free PMC article.

2

Expression of p63 and CK5/6 in early-stage lung squamous cell carcinoma is not only an early diagnostic indicator but also correlates with a good prognosis.

Ma Y, Fan M, Dai L, Kang X, Liu Y, Sun Y, Xiong H, Liang Z, Yan W, Chen K. Ma Y, et al. Among authors: dai l. Thorac Cancer. 2015 May;6(3):288-95. doi: 10.1111/1759-7714.12181. Epub 2015 Apr 24. Thorac Cancer. 2015. PMID: 26273374 Free PMC article.

3

Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.

Shi Q, Shen L, Dong B, Fu H, Kang X, Dai L, Yang Y, Yan W, Chen KN. Shi Q, et al. Among authors: dai l. Thorac Cancer. 2018 Jul;9(7):836-846. doi: 10.1111/1759-7714.12758. Epub 2018 May 14. Thorac Cancer. 2018. PMID: 29757528 Free PMC article.

4

Efficacy of repeated surgery is superior to that of non-surgery for recurrent/second primary lung cancer after initial operation for primary lung cancer.

Zhou H, Kang X, Dai L, Yan W, Yang Y, Lin Y, Chen KN. Zhou H, et al. Among authors: dai l. Thorac Cancer. 2018 Aug;9(8):1062-1068. doi: 10.1111/1759-7714.12790. Epub 2018 Jun 19. Thorac Cancer. 2018. PMID: 29917320 Free PMC article.

5

Survival After Induction Chemotherapy and Esophagectomy Is Not Improved by Adjuvant Chemotherapy.

Yan W, Zhao P, Fu H, Lin Y, Li Z, Dai L, Yang Y, Kang X, Chen KN. Yan W, et al. Among authors: dai l. Ann Thorac Surg. 2019 Nov;108(5):1505-1513. doi: 10.1016/j.athoracsur.2019.04.106. Epub 2019 Jun 21. Ann Thorac Surg. 2019. PMID: 31233722

6

HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair.

Zhou T, Fu H, Dong B, Dai L, Yang Y, Yan W, Shen L. Zhou T, et al. Among authors: dai l. Thorac Cancer. 2020 Nov;11(11):3071-3085. doi: 10.1111/1759-7714.13142. Epub 2019 Sep 30. Thorac Cancer. 2020. PMID: 31568655 Free PMC article.

7

Efficacy of programmed cell death protein 1 inhibitor in resection transformation treatment of esophageal cancer.

Fan M, Dai L, Yan W, Yang Y, Lin Y, Chen K. Fan M, et al. Among authors: dai l. Thorac Cancer. 2021 Aug;12(15):2182-2188. doi: 10.1111/1759-7714.14054. Epub 2021 Jun 17. Thorac Cancer. 2021. PMID: 34137505 Free PMC article.

8

[Outcome after surgery preserving pharynx and larynx for cervical esophageal cancer].

Ma SH, Qin B, Shen LY, Liang Z, Kang XZ, Dai L, Chen KN. Ma SH, et al. Among authors: dai l. Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jan;15(1):63-6. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 22287355 Chinese.

9

The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma.

Du YB, Dong B, Shen LY, Yan WP, Dai L, Xiong HC, Liang Z, Kang XZ, Qin B, Chen KN. Du YB, et al. Among authors: dai l. J Surg Res. 2014 May 15;188(2):442-50. doi: 10.1016/j.jss.2014.01.017. Epub 2014 Jan 17. J Surg Res. 2014. PMID: 24525058

10

Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo.

Li H, Shen LY, Yan WP, Dong B, Kang XZ, Dai L, Yang YB, Fu H, Yang HL, Zhou HT, Huang C, Liang Z, Xiong HC, Chen KN. Li H, et al. Among authors: dai l. PLoS One. 2015 Jun 15;10(6):e0130551. doi: 10.1371/journal.pone.0130551. eCollection 2015. PLoS One. 2015. PMID: 26076456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,517 results

Search Page

Filters